Advertisement

Topics

Vasopressin Receptor Antagonist – Pipeline Insight Report 2018 Featuring Astellas, Bayer, Biovie, Azevan Pharmaceuticals, Ferring & Roche – ResearchAndMarkets.com

13:04 EST 30 Nov 2018 | Biotech 365

DUBLIN–(BUSINESS WIRE)–The “Vasopressin Receptor Antagonist – Pipeline Insight, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering. ‘Vasopressin Receptor Antagonist – Pipeline Insight, 2018’ report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Vasopressin … Continue reading

Original Article: Vasopressin Receptor Antagonist – Pipeline Insight Report 2018 Featuring Astellas, Bayer, Biovie, Azevan Pharmaceuticals, Ferring & Roche – ResearchAndMarkets.com

NEXT ARTICLE

More From BioPortfolio on "Vasopressin Receptor Antagonist – Pipeline Insight Report 2018 Featuring Astellas, Bayer, Biovie, Azevan Pharmaceuticals, Ferring & Roche – ResearchAndMarkets.com"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...